Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older
- PMID: 19027048
- DOI: 10.1016/j.vaccine.2008.11.012
Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older
Abstract
Incidence of zoster and post-herpetic neuralgia (PHN) and associated health care resource utilisation were investigated in the Australian population aged > or =50 years, using general practice data from 2000 to 2006, and pharmaceutical prescribing, hospital morbidity and emergency department data from 1998 to 2005. Zoster and PHN incidence rates were estimated as approximately 10/1000 and 1.45/1000 persons, respectively, with antivirals prescribed for 73.5% of zoster cases. Estimated hospitalisation and emergency department visit rates were 0.67/1000 and 0.38/1000 persons, respectively. Management of zoster (including PHN) involved approximately 2.4 general practitioner consultations. Total costs to the health care system were estimated as approximately 32.8 million per year. The substantial burden of zoster and PHN highlights the potential benefit of zoster vaccination.
Similar articles
-
Burden of disease from shingles and post-herpetic neuralgia in the over 80 year olds in the UK.PLoS One. 2020 Feb 25;15(2):e0229224. doi: 10.1371/journal.pone.0229224. eCollection 2020. PLoS One. 2020. PMID: 32097441 Free PMC article.
-
Herpes zoster vaccination: benefits and barriers.J Am Osteopath Assoc. 2009 Jun;109(6 Suppl 2):S22-4. J Am Osteopath Assoc. 2009. PMID: 19553633 Review.
-
Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.Vaccine. 2007 Nov 28;25(49):8326-37. doi: 10.1016/j.vaccine.2007.09.066. Epub 2007 Oct 17. Vaccine. 2007. PMID: 17980938
-
Herpes zoster vaccine: clinical trial evidence and implications for medical practice.J Am Osteopath Assoc. 2007 Mar;107(3 Suppl 1):S14-8. J Am Osteopath Assoc. 2007. PMID: 17488883 Review.
-
The burden and cost of hospitalised varicella and zoster in Australian children.Vaccine. 2004 Dec 21;23(6):755-61. doi: 10.1016/j.vaccine.2004.07.025. Vaccine. 2004. PMID: 15542199
Cited by
-
A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia Pacific.Hum Vaccin Immunother. 2024 Dec 31;20(1):2344983. doi: 10.1080/21645515.2024.2344983. Epub 2024 May 20. Hum Vaccin Immunother. 2024. PMID: 38767209 Free PMC article. Review.
-
A Cross-Sectional Study of the Knowledge, Practice, and Attitude Towards Herpes Zoster Vaccination Among the General Population in the Western Region of Saudi Arabia.Cureus. 2023 Jan 8;15(1):e33508. doi: 10.7759/cureus.33508. eCollection 2023 Jan. Cureus. 2023. PMID: 36756021 Free PMC article.
-
Reduction in Herpes Zoster Antiviral Use Since the Introduction of the Live-Attenuated Zoster Vaccine on Australia's National Immunisation Program: A Population-Based Study from 1994 to 2019.Infect Dis Ther. 2023 Feb;12(2):711-726. doi: 10.1007/s40121-022-00749-y. Epub 2023 Jan 10. Infect Dis Ther. 2023. PMID: 36626109 Free PMC article.
-
Knowledge, attitudes, and practices of the United Arab Emirates population towards Herpes Zoster vaccination: A cross-sectional study.Hum Vaccin Immunother. 2022 Nov 30;18(5):2073752. doi: 10.1080/21645515.2022.2073752. Epub 2022 May 27. Hum Vaccin Immunother. 2022. PMID: 35622980 Free PMC article.
-
Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review.Ther Adv Vaccines Immunother. 2022 Mar 21;10:25151355221084535. doi: 10.1177/25151355221084535. eCollection 2022. Ther Adv Vaccines Immunother. 2022. PMID: 35340552 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical